Mill Creek Life Sciences produces materials that provide the nutrients and growth factors needed to develop cells used in regenerative medicine. Mill Creek’s lead product, PLTMax, helps grow the cells that are used to treat patients with ALS, damaged hearts, a history of stroke, and more than 20 other diseases and ailments. Mill Creek’s business development plan is built on our continued support and improvement of the culture of stem cells, endothelial cells, and other cells used in the field of regenerative medicine.